Boyd Steven

Director, 10% OwnerEYEGATE PHARMACEUTICALS INC (EYEG) · full profile →Form 4 · filed Jul 29, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$14.5M
Net Open-Market Flow
-$14.5M
Transactions
9
8 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 29, 2021Sell(S)400K$3.00$1.2M1.0M
Jul 28, 2021Sell(S)375K$3.28$1.2M1.4M
Jul 27, 2021Sell(S)582K$3.80$2.2M1.8M
Jul 27, 2021Sell(S)462K$6.45$3.0M3.7M
Jul 27, 2021Sell(S)73K$7.06$516K4.1M
Jul 27, 2021Conversion(C)853K$4.80$4.1M4.2M
Jul 27, 2021Sell(S)729K$5.44$4.0M2.9M
Jul 27, 2021Sell(S)532K$4.59$2.4M2.4M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 27, 2021Conversion(C)4K$00

Transaction Codes

S
Open-market sale
C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-21-030722) within minutes of acceptance. Every field above traces to the original document. Verify it directly: